Studies found that plasma monocytes in patients with diabetes secrete a large amount of CypA in response to hyperglycemia, suggesting that CypA may be a potential secretory marker for T2DM (Ramachandran et al., 2012). This evidence concerns the gene PPIA and type 2 diabetes mellitus.